Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("VARGAFTIG B")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 135

  • Page / 6
Export

Selection :

  • and

Les vers sont en travailVARGAFTIG, B.Europe (Paris. 1923). 1990, Vol 68, Num 729-730, pp 182-183, issn 0014-2751Article

Le déchirement in Aragon : je lègue à la nationVARGAFTIG, B.La Pensée. 1987, Num 260, pp 81-82, issn 0031-4773Article

L'inflexion = The inflexionVARGAFTIG, B.Europe (Paris. 1923). 1994, Vol 72, Num 780, pp 173-185, issn 0014-2751Article

Hydergine® et aggrégation plaquettaire. De la pharmacologie à l'application clinique = Hydergine and thromboaggrégation. Pharmacology and clinical applicationVARGAFTIG, B. B.Gazette médicale de France (1969). 1986, Vol 93, Num 21, issn 0016-5557, 97Article

Biology of airway inflammation: from immunology to altered responsiveness : 68th forum in immunologyVARGAFTIG, B. Boris.Research in immunology (Paris). 1997, Vol 148, Num 1, issn 0923-2494, 83 p.Serial Issue

Etude du métabolisme des phospholipides (PAF-ACETHER) = Study of the metabolism of phospholipids (PAF-ACETHER)VARGAFTIG, B. B.sd, 6 p.Report

Le théâtre du ciel avec le sillage de l'éclair = The theater of heaven with the wake of the flashVARGAFTIG, B.Revue des sciences humaines (Lille). 1996, Num 241, pp 57-59, issn 0035-2195Article

Potentiation and inhibition by clonidine of PAF-acether-induced human platelet activationFOUQUE, F; VARGAFTIG, B. B.European journal of pharmacology. 1987, Vol 135, Num 2, pp 211-218, issn 0014-2999Article

Modifications of experimental bronchopulmonary hyperresponsivenessVARGAFTIG, B. B.American journal of respiratory and critical care medicine. 1997, Vol 156, Num 4, pp S97-S102, issn 1073-449X, 2Conference Paper

PAF: a mediator in search of a diseaseVARGAFTIG, B. B.Clinical reviews in allergy. 1994, Vol 12, Num 4, pp 419-421, issn 0731-8235Article

Rôle des médiateurs lipidiques dans les réactions allergiques = Role of lipid mediators in allergic diseasesPRETOLANI, M; VARGAFTIG, B.Comptes rendus des séances de la Société de biologie et de ses filiales. 1991, Vol 185, Num 1-2, pp 37-45, issn 0037-9026Article

Leukotrienes mediate part of Ova-induced lung effects in mice via EGFRVARGAFTIG, B. Boris; SINGER, Monique.American journal of physiology. Lung cellular and molecular physiology. 2003, Vol 29, Num 4, pp L808-L818, issn 1040-0605Article

Triggering by Paf-acether and adrenaline of cyclooxygenase-independent platelet aggregationFOUQUE, F; VARGAFTIG, B. B.British journal of pharmacology. 1984, Vol 83, Num 3, pp 625-633, issn 0007-1188Article

Effects of nedocromil sodium on antigen-induced conjunctivitis in guinea pigsHOYOS, L; NORRIS, A; VARGAFTIG, B. B et al.Advances in therapy. 2000, Vol 17, Num 1, pp 1-6, issn 0741-238XArticle

Basic concepts in lung immunologyPOULTER, L. W.Research in immunology (Paris). 1997, Vol 148, Num 1, pp 8-13, issn 0923-2494Article

Formation of LTB4 by fMLP-stimulated alveolar macrophages accounts for eosinophil migration in vitroHIDI, R; COËFFIER, E; VARGAFTIG, B. B et al.Journal of leukocyte biology. 1992, Vol 51, Num 5, pp 425-431, issn 0741-5400Article

Interference of the thromboxane antagonist SK&F 88046 with platelet activation and subsequent desensitization by arachidonic acid and the thromboxane mimetics U46619 and EP171VARGAFTIG, B; JOSEPH, D; HATMI, M et al.Thrombosis research. 1987, Vol 46, Num 4, pp 509-517, issn 0049-3848Article

Human platelets stimulated by thrombin produce platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when the degrading enzyme acetyl hydrolase is blockedTOUQUI, L; HAYMI, M; VARGAFTIG, B. B et al.Biochemical journal (London. 1906). 1985, Vol 229, Num 3, pp 811-816, issn 0006-2936Article

The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotrieneLEFORT, J; ROTILIO, D; VARGAFTIG, B. B et al.British journal of pharmacology. 1984, Vol 82, Num 3, pp 565-575, issn 0007-1188Article

Immunobiology of eosinophils in allergy and inflammationCAPRON, M; DESREUMAUX, P.Research in immunology (Paris). 1997, Vol 148, Num 1, pp 29-33, issn 0923-2494Article

Role of interleukin-5 in enhanced migration of eosinophils from airways of immunized guinea-pigsCOËFFIER, E; JOSEPH, D; VARGAFTIG, B. B et al.British journal of pharmacology. 1994, Vol 113, Num 3, pp 749-756, issn 0007-1188Article

PAF-acether-induced synthesis of prostacyclin by human endothelial cellsD'HUMIERES, S; RUSSO-MARIE, F; VARGAFTIG, B. B et al.European journal of pharmacology. 1986, Vol 131, Num 1, pp 13-19, issn 0014-2999Article

Apoptose des éosinophiles humains : molécules impliquées (FAS, BCL-2, CASP-3) et modulation par l'IL-5, l'IFN-gamma et les glucocorticostéroïdes = Human eosinohhil apoptosis : molecules involved (FAS, BCL-2, CASP-3) and modulation by IL-5, IFN-gamma and glucocorticosteroidsDruilhe, Anne; Vargaftig, B. Boris.1998, 331 p.Thesis

Désensibilisation des plaquettes humaines par l'acide arachidonique : son mécanisme, sa modulation par l'AMP cyclique et son emploi pour l'étude des substances anti-inflammatoires et anti-thrombotiquesHatmi, Mohamed; Vargaftig, B. Boris.1987, 150 p.Thesis

Role of immunoglobulins G1 and G2 in anaphylactic shock in the guinea pigDESQUAND, S; ROTHHUT, B; VARGAFTIG, B. B et al.International archives of allergy and applied immunology. 1990, Vol 93, Num 2-3, pp 184-191, issn 0020-5915, 8 p.Article

  • Page / 6